Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment
NCT04883125
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Chronic Myelogenous Leukemia, BCR-ABL Positive
CML, Chronic Phase
Interventions
DRUG:
Pioglitazone 15mg
Sponsor
Mansoura University